 | • レポートコード：GIR-105X03465 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、セフェピムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。セフェピムの種類別市場規模（筋肉内注射、静脈内薬物送達）、用途別市場規模（下気道感染症、尿路感染症、皮膚・軟部組織感染症、腹腔感染症、婦人科感染症、敗血症、好中球性発熱）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・セフェピムの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Baxter、Apotex、B. Braun Medical、Pfizer、Perrigo、Fresenius Kabi、Sandoz (Novartis)、Piramal Critical Care、Meitheal Pharmaceuticals、BMS、Qilu Pharmaceutical、Sinopharm、Shanghai Xinfeng Pharmaceutical、Hebei Huamin Pharmaceutical、Nanjing Haichen Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Guangzhou Baiyunshan Tianxin Pharmaceutical、Yuekang Pharmaceutical Group、Chengdu Beite Pharmaceutical、Jiangsu Hengrui Pharmaceutical、Hainan Star Pharmaceutical、Hainan Hailing Pharmaceutical、Shenzhen Xinlitai Pharmaceutical、Shenzhen Lijian Pharmaceutical、Suzhou Dongrui Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：筋肉内注射、静脈内薬物送達 ・用途別分析2016年-2026年：下気道感染症、尿路感染症、皮膚・軟部組織感染症、腹腔感染症、婦人科感染症、敗血症、好中球性発熱 ・セフェピムの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・セフェピムのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・セフェピムのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・セフェピムの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・セフェピムの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cefepime market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cefepime size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cefepime market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cefepime market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intramuscular Injection
Intravenous Drug Delivery
Market segment by Application can be divided into
Lower Respiratory Tract Infection
Urinary Tract Infection
Skin And Soft Tissue Infections
Abdominal Cavity Infection
Gynecologic Infection
Sepsis
Neutrophilic Fever
The key market players for global Cefepime market are listed below:
Baxter
Apotex
B. Braun Medical
Pfizer
Perrigo
Fresenius Kabi
Sandoz (Novartis)
Piramal Critical Care
Meitheal Pharmaceuticals
BMS
Qilu Pharmaceutical
Sinopharm
Shanghai Xinfeng Pharmaceutical
Hebei Huamin Pharmaceutical
Nanjing Haichen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Baiyunshan Tianxin Pharmaceutical
Yuekang Pharmaceutical Group
Chengdu Beite Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Hainan Star Pharmaceutical
Hainan Hailing Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Shenzhen Lijian Pharmaceutical
Suzhou Dongrui Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cefepime product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cefepime, with price, sales, revenue and global market share of Cefepime in 2018 and 2019.
Chapter 3, the Cefepime competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cefepime breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cefepime market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cefepime sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cefepime Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cefepime Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intramuscular Injection
1.2.3 Intravenous Drug Delivery
1.3 Market Analysis by Application
1.3.1 Overview: Global Cefepime Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Lower Respiratory Tract Infection
1.3.3 Urinary Tract Infection
1.3.4 Skin And Soft Tissue Infections
1.3.5 Abdominal Cavity Infection
1.3.6 Gynecologic Infection
1.3.7 Sepsis
1.3.8 Neutrophilic Fever
1.4 Global Cefepime Market Size & Forecast
1.4.1 Global Cefepime Sales in Value (2016-2026))
1.4.2 Global Cefepime Sales in Volume (2016-2026)
1.4.3 Global Cefepime Price by Type (2016-2026) & (US$/Unit)
1.5 Global Cefepime Production Capacity Analysis
1.5.1 Global Cefepime Total Production Capacity (2016-2026)
1.5.2 Global Cefepime Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cefepime Market Drivers
1.6.2 Cefepime Market Restraints
1.6.3 Cefepime Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Cefepime Product and Services
2.1.4 Baxter Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business
2.2.3 Apotex Cefepime Product and Services
2.2.4 Apotex Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 B. Braun Medical
2.3.1 B. Braun Medical Details
2.3.2 B. Braun Medical Major Business
2.3.3 B. Braun Medical Cefepime Product and Services
2.3.4 B. Braun Medical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Cefepime Product and Services
2.4.4 Pfizer Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Perrigo
2.5.1 Perrigo Details
2.5.2 Perrigo Major Business
2.5.3 Perrigo Cefepime Product and Services
2.5.4 Perrigo Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Cefepime Product and Services
2.6.4 Fresenius Kabi Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Sandoz (Novartis)
2.7.1 Sandoz (Novartis) Details
2.7.2 Sandoz (Novartis) Major Business
2.7.3 Sandoz (Novartis) Cefepime Product and Services
2.7.4 Sandoz (Novartis) Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Piramal Critical Care
2.8.1 Piramal Critical Care Details
2.8.2 Piramal Critical Care Major Business
2.8.3 Piramal Critical Care Cefepime Product and Services
2.8.4 Piramal Critical Care Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Meitheal Pharmaceuticals
2.9.1 Meitheal Pharmaceuticals Details
2.9.2 Meitheal Pharmaceuticals Major Business
2.9.3 Meitheal Pharmaceuticals Cefepime Product and Services
2.9.4 Meitheal Pharmaceuticals Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 BMS
2.10.1 BMS Details
2.10.2 BMS Major Business
2.10.3 BMS Cefepime Product and Services
2.10.4 BMS Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Qilu Pharmaceutical
2.11.1 Qilu Pharmaceutical Details
2.11.2 Qilu Pharmaceutical Major Business
2.11.3 Qilu Pharmaceutical Cefepime Product and Services
2.11.4 Qilu Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Sinopharm
2.12.1 Sinopharm Details
2.12.2 Sinopharm Major Business
2.12.3 Sinopharm Cefepime Product and Services
2.12.4 Sinopharm Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Shanghai Xinfeng Pharmaceutical
2.13.1 Shanghai Xinfeng Pharmaceutical Details
2.13.2 Shanghai Xinfeng Pharmaceutical Major Business
2.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Product and Services
2.13.4 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Hebei Huamin Pharmaceutical
2.14.1 Hebei Huamin Pharmaceutical Details
2.14.2 Hebei Huamin Pharmaceutical Major Business
2.14.3 Hebei Huamin Pharmaceutical Cefepime Product and Services
2.14.4 Hebei Huamin Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Nanjing Haichen Pharmaceutical
2.15.1 Nanjing Haichen Pharmaceutical Details
2.15.2 Nanjing Haichen Pharmaceutical Major Business
2.15.3 Nanjing Haichen Pharmaceutical Cefepime Product and Services
2.15.4 Nanjing Haichen Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Shandong Luoxin Pharmaceutical Group
2.16.1 Shandong Luoxin Pharmaceutical Group Details
2.16.2 Shandong Luoxin Pharmaceutical Group Major Business
2.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Product and Services
2.16.4 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Guangzhou Baiyunshan Tianxin Pharmaceutical
2.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Details
2.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Major Business
2.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product and Services
2.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Yuekang Pharmaceutical Group
2.18.1 Yuekang Pharmaceutical Group Details
2.18.2 Yuekang Pharmaceutical Group Major Business
2.18.3 Yuekang Pharmaceutical Group Cefepime Product and Services
2.18.4 Yuekang Pharmaceutical Group Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Chengdu Beite Pharmaceutical
2.19.1 Chengdu Beite Pharmaceutical Details
2.19.2 Chengdu Beite Pharmaceutical Major Business
2.19.3 Chengdu Beite Pharmaceutical Cefepime Product and Services
2.19.4 Chengdu Beite Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Jiangsu Hengrui Pharmaceutical
2.20.1 Jiangsu Hengrui Pharmaceutical Details
2.20.2 Jiangsu Hengrui Pharmaceutical Major Business
2.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Product and Services
2.20.4 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Hainan Star Pharmaceutical
2.21.1 Hainan Star Pharmaceutical Details
2.21.2 Hainan Star Pharmaceutical Major Business
2.21.3 Hainan Star Pharmaceutical Cefepime Product and Services
2.21.4 Hainan Star Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Hainan Hailing Pharmaceutical
2.22.1 Hainan Hailing Pharmaceutical Details
2.22.2 Hainan Hailing Pharmaceutical Major Business
2.22.3 Hainan Hailing Pharmaceutical Cefepime Product and Services
2.22.4 Hainan Hailing Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Shenzhen Xinlitai Pharmaceutical
2.23.1 Shenzhen Xinlitai Pharmaceutical Details
2.23.2 Shenzhen Xinlitai Pharmaceutical Major Business
2.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Product and Services
2.23.4 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Shenzhen Lijian Pharmaceutical
2.24.1 Shenzhen Lijian Pharmaceutical Details
2.24.2 Shenzhen Lijian Pharmaceutical Major Business
2.24.3 Shenzhen Lijian Pharmaceutical Cefepime Product and Services
2.24.4 Shenzhen Lijian Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Suzhou Dongrui Pharmaceutical
2.25.1 Suzhou Dongrui Pharmaceutical Details
2.25.2 Suzhou Dongrui Pharmaceutical Major Business
2.25.3 Suzhou Dongrui Pharmaceutical Cefepime Product and Services
2.25.4 Suzhou Dongrui Pharmaceutical Cefepime Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cefepime Sales by Manufacturer
3.1 Global Cefepime Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cefepime Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cefepime
3.4 Market Concentration Rate
3.4.1 Top 3 Cefepime Manufacturer Market Share
3.4.2 Top 6 Cefepime Manufacturer Market Share
3.5 Global Cefepime Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cefepime Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cefepime Market Size by Region
4.1.1 Global Cefepime Sales in Volume by Region (2016-2026)
4.1.2 Global Cefepime Revenue by Region (2016-2026)
4.2 North America Cefepime Revenue (2016-2026)
4.3 Europe Cefepime Revenue (2016-2026)
4.4 Asia-Pacific Cefepime Revenue (2016-2026)
4.5 South America Cefepime Revenue (2016-2026)
4.6 Middle East and Africa Cefepime Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cefepime Sales in Volume by Type (2016-2026)
5.2 Global Cefepime Revenue by Type (2016-2026)
5.3 Global Cefepime Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cefepime Sales in Volume by Application (2016-2026)
6.2 Global Cefepime Revenue by Application (2016-2026)
6.3 Global Cefepime Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cefepime Sales by Type (2016-2026)
7.2 North America Cefepime Sales by Application (2016-2026)
7.3 North America Cefepime Market Size by Country
7.3.1 North America Cefepime Sales in Volume by Country (2016-2026)
7.3.2 North America Cefepime Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cefepime Sales by Type (2016-2026)
8.2 Europe Cefepime Sales by Application (2016-2026)
8.3 Europe Cefepime Market Size by Country
8.3.1 Europe Cefepime Sales in Volume by Country (2016-2026)
8.3.2 Europe Cefepime Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cefepime Sales by Type (2016-2026)
9.2 Asia-Pacific Cefepime Sales by Application (2016-2026)
9.3 Asia-Pacific Cefepime Market Size by Region
9.3.1 Asia-Pacific Cefepime Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cefepime Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cefepime Sales by Type (2016-2026)
10.2 South America Cefepime Sales by Application (2016-2026)
10.3 South America Cefepime Market Size by Country
10.3.1 South America Cefepime Sales in Volume by Country (2016-2026)
10.3.2 South America Cefepime Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cefepime Sales by Type (2016-2026)
11.2 Middle East & Africa Cefepime Sales by Application (2016-2026)
11.3 Middle East & Africa Cefepime Market Size by Country
11.3.1 Middle East & Africa Cefepime Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cefepime Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cefepime Typical Distributors
12.3 Cefepime Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cefepime Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cefepime Revenue by Application, (USD Million), 2021-2026
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Cefepime Product and Services
Table 6. Baxter Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Apotex Basic Information, Manufacturing Base and Competitors
Table 8. Apotex Major Business
Table 9. Apotex Cefepime Product and Services
Table 10. Apotex Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. B. Braun Medical Basic Information, Manufacturing Base and Competitors
Table 12. B. Braun Medical Major Business
Table 13. B. Braun Medical Cefepime Product and Services
Table 14. B. Braun Medical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Cefepime Product and Services
Table 18. Pfizer Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Perrigo Basic Information, Manufacturing Base and Competitors
Table 20. Perrigo Major Business
Table 21. Perrigo Cefepime Product and Services
Table 22. Perrigo Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi Major Business
Table 25. Fresenius Kabi Cefepime Product and Services
Table 26. Fresenius Kabi Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sandoz (Novartis) Basic Information, Manufacturing Base and Competitors
Table 28. Sandoz (Novartis) Major Business
Table 29. Sandoz (Novartis) Cefepime Product and Services
Table 30. Sandoz (Novartis) Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Piramal Critical Care Basic Information, Manufacturing Base and Competitors
Table 32. Piramal Critical Care Major Business
Table 33. Piramal Critical Care Cefepime Product and Services
Table 34. Piramal Critical Care Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Meitheal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Meitheal Pharmaceuticals Major Business
Table 37. Meitheal Pharmaceuticals Cefepime Product and Services
Table 38. Meitheal Pharmaceuticals Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. BMS Basic Information, Manufacturing Base and Competitors
Table 40. BMS Major Business
Table 41. BMS Cefepime Product and Services
Table 42. BMS Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Pharmaceutical Major Business
Table 45. Qilu Pharmaceutical Cefepime Product and Services
Table 46. Qilu Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 48. Sinopharm Major Business
Table 49. Sinopharm Cefepime Product and Services
Table 50. Sinopharm Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Shanghai Xinfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Shanghai Xinfeng Pharmaceutical Major Business
Table 53. Shanghai Xinfeng Pharmaceutical Cefepime Product and Services
Table 54. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Hebei Huamin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Hebei Huamin Pharmaceutical Major Business
Table 57. Hebei Huamin Pharmaceutical Cefepime Product and Services
Table 58. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Nanjing Haichen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Nanjing Haichen Pharmaceutical Major Business
Table 61. Nanjing Haichen Pharmaceutical Cefepime Product and Services
Table 62. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Shandong Luoxin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 64. Shandong Luoxin Pharmaceutical Group Major Business
Table 65. Shandong Luoxin Pharmaceutical Group Cefepime Product and Services
Table 66. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Guangzhou Baiyunshan Tianxin Pharmaceutical Major Business
Table 69. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product and Services
Table 70. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Yuekang Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 72. Yuekang Pharmaceutical Group Major Business
Table 73. Yuekang Pharmaceutical Group Cefepime Product and Services
Table 74. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Chengdu Beite Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Chengdu Beite Pharmaceutical Major Business
Table 77. Chengdu Beite Pharmaceutical Cefepime Product and Services
Table 78. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Jiangsu Hengrui Pharmaceutical Major Business
Table 81. Jiangsu Hengrui Pharmaceutical Cefepime Product and Services
Table 82. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Hainan Star Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Hainan Star Pharmaceutical Major Business
Table 85. Hainan Star Pharmaceutical Cefepime Product and Services
Table 86. Hainan Star Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Hainan Hailing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Hainan Hailing Pharmaceutical Major Business
Table 89. Hainan Hailing Pharmaceutical Cefepime Product and Services
Table 90. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Shenzhen Xinlitai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Shenzhen Xinlitai Pharmaceutical Major Business
Table 93. Shenzhen Xinlitai Pharmaceutical Cefepime Product and Services
Table 94. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Shenzhen Lijian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 96. Shenzhen Lijian Pharmaceutical Major Business
Table 97. Shenzhen Lijian Pharmaceutical Cefepime Product and Services
Table 98. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Suzhou Dongrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Suzhou Dongrui Pharmaceutical Major Business
Table 101. Suzhou Dongrui Pharmaceutical Cefepime Product and Services
Table 102. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Global Cefepime Sales by Manufacturer (2019-2021e) & (K Units)
Table 104. Global Cefepime Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 105. Market Position of Manufacturers in Cefepime, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 106. Global Cefepime Production Capacity by Company, (K Units): 2020 VS 2021
Table 107. Head Office and Cefepime Production Site of Key Manufacturer
Table 108. Cefepime New Entrant and Capacity Expansion Plans
Table 109. Cefepime Mergers & Acquisitions in the Past Five Years
Table 110. Global Cefepime Sales by Region (2016-2021e) & (K Units)
Table 111. Global Cefepime Sales by Region (2021-2026) & (K Units)
Table 112. Global Cefepime Revenue by Region (2016-2021e) & (USD Million)
Table 113. Global Cefepime Revenue by Region (2021-2026) & (USD Million)
Table 114. Global Cefepime Sales by Type (2016-2021e) & (K Units)
Table 115. Global Cefepime Sales by Type (2021-2026) & (K Units)
Table 116. Global Cefepime Revenue by Type (2016-2021e) & (USD Million)
Table 117. Global Cefepime Revenue by Type (2021-2026) & (USD Million)
Table 118. Global Cefepime Price by Type (2016-2021e) & (US$/Unit)
Table 119. Global Cefepime Price by Type (2021-2026) & (US$/Unit)
Table 120. Global Cefepime Sales by Application (2016-2021e) & (K Units)
Table 121. Global Cefepime Sales by Application (2021-2026) & (K Units)
Table 122. Global Cefepime Revenue by Application (2016-2021e) & (USD Million)
Table 123. Global Cefepime Revenue by Application (2021-2026) & (USD Million)
Table 124. Global Cefepime Price by Application (2016-2021e) & (US$/Unit)
Table 125. Global Cefepime Price by Application (2021-2026) & (US$/Unit)
Table 126. North America Cefepime Sales by Country (2016-2021e) & (K Units)
Table 127. North America Cefepime Sales by Country (2021-2026) & (K Units)
Table 128. North America Cefepime Revenue by Country (2016-2021e) & (USD Million)
Table 129. North America Cefepime Revenue by Country (2021-2026) & (USD Million)
Table 130. North America Cefepime Sales by Type (2016-2021e) & (K Units)
Table 131. North America Cefepime Sales by Type (2021-2026) & (K Units)
Table 132. North America Cefepime Sales by Application (2016-2021e) & (K Units)
Table 133. North America Cefepime Sales by Application (2021-2026) & (K Units)
Table 134. Europe Cefepime Sales by Country (2016-2021e) & (K Units)
Table 135. Europe Cefepime Sales by Country (2021-2026) & (K Units)
Table 136. Europe Cefepime Revenue by Country (2016-2021e) & (USD Million)
Table 137. Europe Cefepime Revenue by Country (2021-2026) & (USD Million)
Table 138. Europe Cefepime Sales by Type (2016-2021e) & (K Units)
Table 139. Europe Cefepime Sales by Type (2021-2026) & (K Units)
Table 140. Europe Cefepime Sales by Application (2016-2021e) & (K Units)
Table 141. Europe Cefepime Sales by Application (2021-2026) & (K Units)
Table 142. Asia-Pacific Cefepime Sales by Region (2016-2021e) & (K Units)
Table 143. Asia-Pacific Cefepime Sales by Region (2021-2026) & (K Units)
Table 144. Asia-Pacific Cefepime Revenue by Region (2016-2021e) & (USD Million)
Table 145. Asia-Pacific Cefepime Revenue by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Cefepime Sales by Type (2016-2021e) & (K Units)
Table 147. Asia-Pacific Cefepime Sales by Type (2021-2026) & (K Units)
Table 148. Asia-Pacific Cefepime Sales by Application (2016-2021e) & (K Units)
Table 149. Asia-Pacific Cefepime Sales by Application (2021-2026) & (K Units)
Table 150. South America Cefepime Sales by Country (2016-2021e) & (K Units)
Table 151. South America Cefepime Sales by Country (2021-2026) & (K Units)
Table 152. South America Cefepime Revenue by Country (2016-2021e) & (USD Million)
Table 153. South America Cefepime Revenue by Country (2021-2026) & (USD Million)
Table 154. South America Cefepime Sales by Type (2016-2021e) & (K Units)
Table 155. South America Cefepime Sales by Type (2021-2026) & (K Units)
Table 156. South America Cefepime Sales by Application (2016-2021e) & (K Units)
Table 157. South America Cefepime Sales by Application (2021-2026) & (K Units)
Table 158. Middle East & Africa Cefepime Sales by Country (2016-2021e) & (K Units)
Table 159. Middle East & Africa Cefepime Sales by Country (2021-2026) & (K Units)
Table 160. Middle East & Africa Cefepime Revenue by Country (2016-2021e) & (USD Million)
Table 161. Middle East & Africa Cefepime Revenue by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Cefepime Sales by Type (2016-2021e) & (K Units)
Table 163. Middle East & Africa Cefepime Sales by Type (2021-2026) & (K Units)
Table 164. Middle East & Africa Cefepime Sales by Application (2016-2021e) & (K Units)
Table 165. Middle East & Africa Cefepime Sales by Application (2021-2026) & (K Units)
Table 166. Direct Channel Pros & Cons
Table 167. Indirect Channel Pros & Cons
Table 168. Cefepime Typical Distributors
Table 169. Cefepime Typical Customers
List of Figures
Figure 1. Cefepime Picture
Figure 2. Global Cefepime Sales Market Share by Type in 2020
Figure 3. Intramuscular Injection
Figure 4. Intravenous Drug Delivery
Figure 5. Global Cefepime Sales Market Share by Application in 2020
Figure 6. Lower Respiratory Tract Infection
Figure 7. Urinary Tract Infection
Figure 8. Skin And Soft Tissue Infections
Figure 9. Abdominal Cavity Infection
Figure 10. Gynecologic Infection
Figure 11. Sepsis
Figure 12. Neutrophilic Fever
Figure 13. Global Cefepime Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Cefepime Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Cefepime Sales (2016-2026) & (K Units)
Figure 16. Global Cefepime Price by Type (2016-2026) & (US$/Unit)
Figure 17. Global Cefepime Production Capacity (2016-2026) & (K Units)
Figure 18. Global Cefepime Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Cefepime Market Drivers
Figure 20. Cefepime Market Restraints
Figure 21. Cefepime Market Trends
Figure 22. Global Cefepime Sales Market Share by Manufacturer in 2020
Figure 23. Global Cefepime Revenue Market Share by Manufacturer in 2020
Figure 24. Cefepime Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Cefepime Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Cefepime Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Cefepime Sales Market Share by Region (2016-2026)
Figure 28. Global Cefepime Revenue Market Share by Region (2016-2026)
Figure 29. North America Cefepime Revenue (2016-2026) & (USD Million)
Figure 30. Europe Cefepime Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Cefepime Revenue (2016-2026) & (USD Million)
Figure 32. South America Cefepime Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Cefepime Revenue (2016-2026) & (USD Million)
Figure 34. Global Cefepime Sales Market Share by Type (2016-2026)
Figure 35. Global Cefepime Revenue Market Share by Type (2016-2026)
Figure 36. Global Cefepime Price by Type (2016-2026) & (US$/Unit)
Figure 37. Global Cefepime Sales Market Share by Application (2016-2026)
Figure 38. Global Cefepime Revenue Market Share by Application (2016-2026)
Figure 39. Global Cefepime Price by Application (2016-2026) & (US$/Unit)
Figure 40. North America Cefepime Sales Market Share by Type (2016-2026)
Figure 41. North America Cefepime Sales Market Share by Application (2016-2026)
Figure 42. North America Cefepime Sales Market Share by Country (2016-2026)
Figure 43. North America Cefepime Revenue Market Share by Country (2016-2026)
Figure 44. United States Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Cefepime Sales Market Share by Type (2016-2026)
Figure 48. Europe Cefepime Sales Market Share by Application (2016-2026)
Figure 49. Europe Cefepime Sales Market Share by Country (2016-2026)
Figure 50. Europe Cefepime Revenue Market Share by Country (2016-2026)
Figure 51. Germany Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Cefepime Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Cefepime Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Cefepime Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Cefepime Revenue Market Share by Region (2016-2026)
Figure 60. China Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Cefepime Sales Market Share by Type (2016-2026)
Figure 67. South America Cefepime Sales Market Share by Application (2016-2026)
Figure 68. South America Cefepime Sales Market Share by Country (2016-2026)
Figure 69. South America Cefepime Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Cefepime Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Cefepime Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Cefepime Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Cefepime Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Cefepime Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
上部気道感染症治療の世界市場2018-2025 In 2018, the global Upper Respiratory Tract Infection Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Upper Re…- 院内感染治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…
- 世界のセフェピムAPI市場 2021：企業別、地域別、種類・用途別 The Cefepime API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界のブドウ球菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Staphylococcal Infection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の細菌性眼感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Bacterial Eye Infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …